Home › NDC Lookup › RxCUI directory › RxCUI 2673304

Lidocaine 0.04 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment — RxCUI 2673304

RxNorm drug concept · Semantic clinical drug
RxCUI 2673304 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2673304
Official nameLidocaine 0.04 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine 4 % / phenylephrine HCl 0.25 % Rectal Ointment
FDA products mapped6
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine 0.04 MG/MG / phenylephrine hydrochlori... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine 0.04 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment RxCUI 2673304

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
    • Phenylephrine 8163
    • Lidocaine / phenylephrine 226976
    • Phenylephrine hydrochloride 8164
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine / phenylephrine Rectal Ointment 2672352
    • Lidocaine / phenylephrine hydrochloride Rectal Ointment 2672353
    • Lidocaine / phenylephrine Rectal Product 1314134
    • Lidocaine / phenylephrine hydrochloride Rectal Product 2662038
    • Rectal Ointment 317005
    • Rectal Product 1151127
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lidocaine 0.04 MG/MG 340128
    • Phenylephrine hydrochloride 0.0025 MG/MG 1114861

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lidocaine 0.04 MG/MG SCDC · 340128
  • Phenylephrine hydrochloride 0.0025 MG/MG SCDC · 1114861
  • Lidocaine / phenylephrine Rectal Ointment SCDF · 2672352
  • Lidocaine / phenylephrine hydrochloride Rectal Ointment SCDFP · 2672353
  • Lidocaine / phenylephrine Rectal Product SCDG · 1314134
  • Lidocaine / phenylephrine hydrochloride Rectal Product SCDGP · 2662038

📦 FDA Products & Package NDCs

6 products · 9 package NDCs
9 package NDCs map to RxCUI 2673304 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63742-0045-01 45 g in 1 TUBE, WITH APPLICATOR (63742-045-01) Hemorrhoid Master Clinical Resolution Laboratory, Inc. 2019-11-01
70942-0357-01 1 TUBE in 1 CARTON (70942-357-01) / 28 g in 1 TUBE (70942-3... Dr Butlers Hemorrhoid and Fissure PF Beyond Health P.A. 2023-02-20
70942-0357-12 12 PACKET in 1 CARTON (70942-357-12) / 2 g in 1 PACKET (709... Dr Butlers Hemorrhoid and Fissure PF Beyond Health P.A. 2023-02-20
70942-0357-15 1 TUBE in 1 CARTON (70942-357-15) / 42.5 g in 1 TUBE (70942... Dr Butlers Hemorrhoid and Fissure PF Beyond Health P.A. 2025-12-01
70942-0357-75 1 TUBE in 1 CARTON (70942-357-75) / 21.3 g in 1 TUBE (70942... Dr Butlers Hemorrhoid and Fissure PF Beyond Health P.A. 2025-07-22
72654-0002-01 45 g in 1 TUBE (72654-002-01) Hemorrhoid Master Ebanel Laboratories, Inc 2019-11-01
82433-0446-00 1 TUBE in 1 BOX (82433-446-00) / 28 g in 1 TUBE RRHOID RAGE Hemorrhoidal POPPY COLLECTIVE LLC 2024-02-12
82433-0946-00 1 TUBE in 1 BOX (82433-946-00) / 28 g in 1 TUBE The Femme Fix Hemorrhoid Treatment POPPY COLLECTIVE LLC 2025-05-01
84735-0008-01 50 g in 1 TUBE (84735-008-01) LIPOSOMAL HEMORRHOID MASTER Hengyang Chuangjiujia Trading Co., Ltd. 2025-05-12
Observed labelers: Beyond Health P.A. (4) · POPPY COLLECTIVE LLC (2) · Clinical Resolution Laboratory, Inc. (1) · Ebanel Laboratories, Inc (1) · Hengyang Chuangjiujia Trading Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.